Kapitalo Investimentos’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,186
Closed -$110K 187
2024
Q4
$110K Buy
+1,186
New +$107K 0.07% 151
2024
Q1
Sell
-3,077
Closed -$249K 378
2023
Q4
$249K Sell
3,077
-2,793
-48% -$217K 0.05% 232
2023
Q3
$440K Buy
5,870
+3,959
+207% +$305K 0.06% 127
2023
Q2
$147K Sell
1,911
-1,540
-45% -$123K 0.03% 296
2023
Q1
$286K Buy
+3,451
New +$286K 0.09% 86

Other funds holding GILD

Kapitalo Investimentos's GILD Position: Q1 2025 in Review

Kapitalo Investimentos sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 1,186 shares — an estimated $110K sold.

Kapitalo Investimentos first reported a position in GILD in Q1 2023 and held it in 5 quarters. The position peaked at $440K in Q3 2023. 2,014 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

  • Kapitalo Investimentos reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
  • Kapitalo Investimentos sold 1,186 Gilead Sciences shares in Q1 2025, an estimated $110K.
  • Kapitalo Investimentos first reported a position in Gilead Sciences in Q1 2023 and held it in 5 quarters.
  • Kapitalo Investimentos's Gilead Sciences position peaked at $440K in Q3 2023.
  • 2,014 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Kapitalo Investimentos's 13F filing for Q1 2025, filed 7 May 2025.